Welcome to LookChem.com Sign In|Join Free
  • or
1-(3,4,5-Trimethoxy-phenyl)-ethylamine, commonly known as TMA-6, is a phenethylamine chemical compound with structural similarities to the hallucinogenic drug mescaline. It possesses psychoactive properties and is known to bind to the serotonin receptor, mediating its hallucinogenic effects in humans. TMA-6 has been studied for its potential therapeutic effects, particularly in the treatment of depression and anxiety, although its safety and efficacy for medical use have not been firmly established.

121082-99-3

Post Buying Request

121082-99-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

121082-99-3 Usage

Uses

Used in Pharmaceutical Research:
TMA-6 is used as a research compound for its psychoactive properties, primarily in the investigation of its potential therapeutic effects on mental health conditions such as depression and anxiety. Its interaction with the serotonin receptor makes it a subject of interest for understanding the mechanisms of action in relation to mood regulation.
Used in Neuropharmacological Studies:
In the field of neuropharmacology, TMA-6 serves as a tool to explore the role of serotonin receptors in modulating hallucinogenic experiences and their underlying neural pathways. This can contribute to the development of a deeper understanding of the neurobiological basis of hallucinations and related phenomena.

Check Digit Verification of cas no

The CAS Registry Mumber 121082-99-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,0,8 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 121082-99:
(8*1)+(7*2)+(6*1)+(5*0)+(4*8)+(3*2)+(2*9)+(1*9)=93
93 % 10 = 3
So 121082-99-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H17NO3/c1-7(12)8-5-9(13-2)11(15-4)10(6-8)14-3/h5-7H,12H2,1-4H3/p+1/t7-/m1/s1

121082-99-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-(3,4,5-trimethoxyphenyl)ethanamine

1.2 Other means of identification

Product number -
Other names 3,4,5-trimethoxyphenyl ethyl amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:121082-99-3 SDS

121082-99-3Downstream Products

121082-99-3Relevant academic research and scientific papers

APPLICATIONS OF N6-SUBSTITUTED ADENOSINE DERIVATIVE AND N6-SUBSTITUTED ADENINE DERIVATIVE TO CALMING, HYPNOSES, CONVULSION RESISTANCE, EPILEPTIC RESISTANCE, PARKINSON DISEASE RESISTANCE, AND DEMENTIA PREVENTION AND TREATMENT

-

Paragraph 0144, (2018/10/27)

PROBLEM TO BE SOLVED: To prepare analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. SOLUTION: The present invention relates to an N6-substituted adenosine derivative and an N6-substituted adenine derivative selected from the group consisting of specific compounds. The present invention also relates to a pharmaceutical composition at least comprising a therapeutically effective amount of the compounds and a pharmaceutically acceptable carrier. The invention further relates to the compounds used in preparation of analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. COPYRIGHT: (C)2016,JPO&INPIT

NOVEL MODULATORS OF PROTEIN KINASE SIGNALING

-

Page/Page column 59-60, (2009/12/28)

The present invention provides new tyrphostin derivatives acting as protein kinase (PK) and receptor kinase (RK) signaling modulators. The invention further provides methods of their preparation, pharmaceutical compositions including such compounds, and m

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 121082-99-3